KR102007569B1 - Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same - Google Patents
Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same Download PDFInfo
- Publication number
- KR102007569B1 KR102007569B1 KR1020170149248A KR20170149248A KR102007569B1 KR 102007569 B1 KR102007569 B1 KR 102007569B1 KR 1020170149248 A KR1020170149248 A KR 1020170149248A KR 20170149248 A KR20170149248 A KR 20170149248A KR 102007569 B1 KR102007569 B1 KR 102007569B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- island
- extract
- fermented
- osl
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 74
- 230000004151 fermentation Effects 0.000 title claims abstract description 74
- 240000006891 Artemisia vulgaris Species 0.000 title claims abstract description 69
- 235000003261 Artemisia vulgaris Nutrition 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 12
- 235000019629 palatability Nutrition 0.000 title abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 28
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 240000001929 Lactobacillus brevis Species 0.000 claims description 59
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 46
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 37
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 35
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 35
- 239000001138 artemisia absinthium Substances 0.000 claims description 35
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 35
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 34
- 241000894006 Bacteria Species 0.000 claims description 26
- 239000004310 lactic acid Substances 0.000 claims description 23
- 235000014655 lactic acid Nutrition 0.000 claims description 23
- 241000233866 Fungi Species 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 16
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 13
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 235000003826 Artemisia Nutrition 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 3
- 235000009052 artemisia Nutrition 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 102000004366 Glucosidases Human genes 0.000 claims 1
- 108010056771 Glucosidases Proteins 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 15
- 239000006041 probiotic Substances 0.000 abstract description 15
- 235000018291 probiotics Nutrition 0.000 abstract description 15
- 230000003178 anti-diabetic effect Effects 0.000 abstract description 14
- 239000003963 antioxidant agent Substances 0.000 abstract description 13
- 239000004480 active ingredient Substances 0.000 abstract description 10
- 230000001976 improved effect Effects 0.000 abstract description 9
- 235000019640 taste Nutrition 0.000 abstract description 6
- 235000013376 functional food Nutrition 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 244000068988 Glycine max Species 0.000 abstract description 2
- 235000010469 Glycine max Nutrition 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000000529 probiotic effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000003472 antidiabetic agent Substances 0.000 description 4
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 4
- 239000003613 bile acid Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229940119569 wormwood extract Drugs 0.000 description 4
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- -1 larvae Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241001435059 Artemisia argyi Species 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 240000003296 Petasites japonicus Species 0.000 description 2
- 235000003823 Petasites japonicus Nutrition 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000001436 butterbur Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 235000001405 Artemisia annua Nutrition 0.000 description 1
- 240000000011 Artemisia annua Species 0.000 description 1
- 241000092666 Artemisia iwayomogi Species 0.000 description 1
- 235000007806 Artemisia iwayomogi Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000186679 Lactobacillus buchneri Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- ZBDGHWFPLXXWRD-JGWLITMVSA-N methyl beta-D-xylopyranoside Chemical compound CO[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O ZBDGHWFPLXXWRD-JGWLITMVSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/121—Brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
-
- A23Y2220/13—
-
- A23Y2220/67—
-
- A23Y2260/35—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 기호도 및 기능성이 향상된 섬애쑥 발효물, 이의 제조방법, 및 상기 발효물의 제조를 위한 발효 균주에 관한 것이다. 본 발명에 따른 섬애쑥 발효물은, 종래 섬애쑥 추출물에 비해 항산화 및 항당뇨 효과가 강화되고, 색상, 맛 등을 포함하는 전체적인 기호도가 향상되었는바, 프로바이오틱스 등 건강 기능성 식품의 유효성분으로 활용될 수 있을 것이다. The present invention relates to a fermented soybean fermented product having improved palatability and functionality, a method for preparing the same, and a fermentation strain for preparing the fermented product. The island's mugwort fermented product according to the present invention has enhanced antioxidant and antidiabetic effects, and improved overall preference including color, taste, and the like compared to conventional island's mulberry extract, and can be utilized as an active ingredient in health functional foods such as probiotics. Could be.
Description
본 발명은 기호도 및 기능성이 향상된 섬애쑥 발효물, 이의 제조방법, 및 상기 발효물의 제조를 위한 발효 균주에 관한 것이다. The present invention relates to a fermented soybean fermented product having improved palatability and functionality, a method for preparing the same, and a fermentation strain for preparing the fermented product.
쑥속(Artemisia spp.) 식물은 우리나라 전국의 산야에 분포하는 여러해살이 풀로, 국화과(Compositae)에 속하는 다년생 초본이고 북반구에 약 200여종이 알려져 있다. 우리나라에 38종이 분포한다고 보고되고 있으나, 종의 구분은 명확하게 이루어지지 않고 있으며, 민간에서 쑥속 식물은 약쑥, 애엽, 애자 등으로 불리고 예로부터 식용으로 사용되고 있다. 약용으로는 쏙속 식물의 하나인 더위지기(Artemisia iwayomogi Kitamura)의 전초를 인진호(茵蔯蒿)라 부르고, 황달, 해열, 진통, 지혈에 사용하였으며, 개똥쑥(Artemisia annua Linne)은 항말라리아 효과를 가지는 아르테미시닌(artemisinin)의 원료 생약으로 알려져 있다. Artemisia spp. Is a perennial herb that is distributed in mountain fields all over Korea. It is a perennial herb belonging to the genus Compositae and about 200 species are known in the northern hemisphere. It is reported that there are 38 species distributed in Korea, but the classification of species is not clearly made, and the wormwood plants are called wormwood, larvae, insulators etc. in folklore and have been used for edible since ancient times. For medical purposes, the outpost of Artemisia iwayomogi Kitamura, one of the genus plants, is called injinho, and it is used for jaundice, fever, pain and hemostasis, and Artemisia annua Linne has an antimalarial effect. Eggplant is known as a raw herbal medicine of artemisinin.
한편, 섬애쑥은 황해쑥(Artemisia argyi)의 변이종으로서 남해 지역에서 자생하는 약쑥으로 알려져 있으며, 유전적인 특성과 형태적 특성을 인정받아 국내 최초로 품종보호 등록된 바 있다(2013년 09월). 일반 약쑥에 비해 우수한 항산화 활성 등 생리 활성으로 인해, 그 재배 면적이 2010년 1ha에서 2013년 20ha 이상으로 증가한 이래, 섬애쑥의 재배 면적은 매년 급속도로 늘어나고 있다. 섬애쑥의 기능성을 활용한 식품, 화장품, 보건용품 등, 그 활용도를 높이기 위한 연구가 추진된 바 있으나, 현재까지는 약쑥 자체의 생리 활성과 단순한 가공품 개발 위주로만 진행되고 있어, 지역 특화작목으로 정착하기 위해서는 기능성 향상에 초점을 맞춘 가공품의 개발이 시급하다. 이 뿐만 아니라, 섬애쑥은 고유의 쓴 맛으로 인해 프로바이오틱스 등과 같은 식품으로 적용함에 한계를 보이고 있는바, 기능성뿐만 아니라, 기호도의 증진 역시 중요한 기술적 요소라 할 수 있다.On the other hand, the island mugwort is a mutant of Artemisia argyi, known as a wormwood native to the South Sea region, and was recognized for its genetic and morphological characteristics for the first time in Korea. Due to its physiological activity such as superior antioxidant activity compared to common wormwood, the planting area of island mugwort has been increasing rapidly every year since its growing area increased from 1 ha in 2010 to more than 20 ha in 2013. Research has been conducted to enhance the utilization of food, cosmetics, and health care products that utilize the functionality of the island wormwood, but until now, only the physiological activity of wormwood itself and the development of simple processed products have been conducted. For this purpose, it is urgent to develop a processed product focused on improving the functionality. In addition, because the intrinsic bitter taste of the island is showing a limit to apply to foods such as probiotics, bar as well as functionality, the enhancement of preference is also an important technical factor.
이러한 배경 하에서, 섬애쑥의 기능성뿐만 아니라, 기호도 역시 향상시킬 수 있는 섬애쑥의 생산 또는 가공 기술에 대한 연구가 활발히 진행되고 있으나 (한국 등록특허 10-1310019), 아직은 미비한 실정이다. 이에, 본 발명은 프로바이오틱스 유산균 등을 활용하여 식물 발효시킴으로써, 정장 기능, 항당뇨 활성 등의 기능성 증진 및 기호도 개선을 목적으로 하였다.Under these circumstances, research on the production or processing technology of island mulberry, which can improve not only the functionality of the island mulberry, but also the taste, is actively underway (Korea Patent 10-1310019), but it is still inadequate. Accordingly, the present invention was intended for plant fermentation using probiotics lactic acid bacteria and the like, to improve the functional and palatability of intestinal function, antidiabetic activity and the like.
본 발명은 상기와 같은 문제점을 해결하기 위해 안출된 것으로서, 본 발명자들은 락토바실러스 브레비스 등의 균주를 이용하여 제조된 섬애쑥 발효물은, 종래 섬애쑥 추출물에 비해 항산화 및 항당뇨 효과가 강화되고, 색상, 맛 등을 포함하는 전체적인 기호도가 향상됨을 확인하고, 이에 기초하여 본 발명을 완성하였다. The present invention has been made to solve the above problems, the inventors of the present invention is a fungus produced by using a strain, such as Lactobacillus brevis, the antioxidant and anti-diabetic effect is enhanced compared to the conventional extracts It was confirmed that the overall preference including color, taste, and the like was improved, and based on this, the present invention was completed.
본 발명의 목적은 기호도 및 기능성이 향상된 섬애쑥 발효물 및 이의 제조방법을 제공하는데 있다. It is an object of the present invention to provide fermented cabbage fermented with palatability and functionality and a method for producing the same.
본 발명의 다른 목적은 상기 섬애쑥 발효물을 유효성분으로 포함하는, 프로바이오틱스 또는 건강 기능성 식품 조성물을 제공하는데 있다. Another object of the present invention to provide a probiotic or health functional food composition comprising the fermented wormwood as an active ingredient.
본 발명의 또 다른 목적은 우수한 섬애쑥 발효 효능을 지닌 락토바실러스 브레비스 osl 3 균주 (Lactobacillus brevis osl 3, KFCC 11715P)를 제공하는데 있다. Another object of the present invention is Lactobacillus brevis strain Lactobacillus brevis
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problem, another task that is not mentioned will be clearly understood by those skilled in the art from the following description.
상기와 같은 본 발명의 목적을 달성하기 위하여, 본 발명은 섬애쑥 추출물을 락토바실러스 브레비스(Lactobacillus brevis), 류코노스톡 메센테로이데스(Leuconostoc mesenteroides), 및 락토바실러스 플란타륨(Lactobacillus plantarum)으로 이루어진 군으로부터 선택되는 유산균 또는 이의 배양물로 발효시킨, 알파-글루코시다아제(α-glucosidase) 저해 활성이 증진된 섬애쑥 발효물을 제공한다. In order to achieve the object of the present invention as described above, the present invention consists of the island extract of Lactobacillus brevis ( Lactobacillus brevis ), Leuconostoc mesenteroides ( Luconostoc mesenteroides ), and Lactobacillus plantarum ( Lactobacillus plantarum ) Provided is a wormwood fermented product having enhanced alpha-glucosidase inhibitory activity, fermented with a lactic acid bacterium selected from the group or a culture thereof.
본 발명의 일 구현예로서, 상기 섬애쑥 추출물은 섬애쑥 수추출물일 수 있다. In one embodiment of the present invention, the extract may be a mugwort extract.
본 발명의 다른 구현예로서, 상기 유산균은 락토바실러스 브레비스일 수 있고, 바람직하게, 산야초 발효액에서 분리된 락토바실러스 브레비스, 보다 구체적으로, 락토바실러스 브레비스 osl 3 균주 (Lactobacillus brevis osl 3, KFCC 11715P)일 수 있다. In another embodiment of the present invention, the lactic acid bacteria may be Lactobacillus brevis, preferably, Lactobacillus brevis, more specifically, Lactobacillus brevis osl 3 strain ( Lactobacillus brevis) isolated from the wild grass fermentation broth.
또한 본 발명은 섬애쑥 추출물에 유산균 또는 유산균의 배양물을 첨가하여 발효시키는 단계를 포함하는, 알파-글루코시다아제 저해 활성이 증진된 섬애쑥 발효물의 제조방법으로서, 상기 유산균은 락토바실러스 브레비스, 류코노스톡 메센테로이데스, 및 락토바실러스 플란타륨으로 이루어진 군으로부터 선택되는, 섬애쑥 발효물의 제조방법을 제공한다,In another aspect, the present invention comprises the step of fermentation by adding a culture of lactic acid bacteria or lactic acid bacteria to the extract of the fungus, Al-glucosidase inhibitory activity of the preparation method of the fungus of the fungus, the lactic acid bacteria Lactobacillus brevis, Provided is a method for preparing a wormwood fermented product selected from the group consisting of Conostoke Mesenteroides, and Lactobacillus plantarium,
본 발명의 일 구현예로서, 상기 발효시키는 단계 이전에, 섬애쑥 추출물에 정제수 및 영양성분을 첨가하여 발효 전 혼합물을 형성하는 단계를 추가로 포함할 수 있으며, 상기 영양성분은 맥아 추출물, 구체적으로 맥아 수추출물일 수 있다. As an embodiment of the present invention, prior to the fermentation step, may further comprise the step of forming a mixture before fermentation by adding purified water and nutrients to the island mulberry extract, the nutrients are malt extract, specifically It may be malt extract.
본 발명의 또 다른 구현예로서, 상기 유산균은 락토바실러스 브레비스 osl 3 균주 (Lactobacillus brevis osl 3, KFCC 11715P)일 수 있다. As another embodiment of the present invention, the lactic acid bacteria may be Lactobacillus brevis
본 발명의 다른 구현예로서 상기 발효시키는 단계는, 26 내지 32℃에서 48시간 내지 96시간 동안 실시할 수 있다. As another embodiment of the present invention, the step of fermentation may be performed at 26 to 32 ° C. for 48 hours to 96 hours.
또한, 본 발명은 우수한 섬애쑥 발효 효능을 지닌 락토바실러스 브레비스 osl 3 균주 (Lactobacillus brevis osl 3, KFCC 11715P)를 제공한다. Further, the present invention provides a Lactobacillus brevis
또한, 본 발명은 상기 섬애쑥 발효물을 유효성분으로 포함하는, 항산화 및/또는 항당뇨 프로바이오틱스 조성물 및 이의 용도를 제공한다.The present invention also provides an anti-diabetic and / or antidiabetic probiotic composition and its use, comprising the fermented wormwood as an active ingredient.
락토바실러스 브레비스 등의 균주를 이용하여 제조된 섬애쑥 발효물은, 종래 섬애쑥 추출물에 비해 항산화 및 항당뇨 효과가 강화되고, 색상, 맛 등을 포함하는 전체적인 기호도가 향상되었는바, 프로바이오틱스 등 건강 기능성 식품의 유효성분으로 활용될 수 있을 것이다. The wormwood fermented product prepared using strains such as Lactobacillus brevis has enhanced antioxidant and anti-diabetic effects and improved overall preference including color and taste compared to conventional wormwood extracts. It can be used as an active ingredient in food.
도 1은, 일반 쑥과 섬애쑥의 외형적 특성을 비교한 것으로서, 도 1의 a는 일반 쑥을 육안으로 관찰한 결과, 및 도 1의 b는 섬애쑥을 육안으로 관찰한 결과이다.
도 2는, 산야초 발효액으로부터 분리한 균주의 세포 지방산 조성을 GLC로 분석한 결과이다.
도 3은, 산야초 발효액으로부터 분리한 균주를 동정한 것으로서, 도 3의 a는 16S rDNA 염기서열에 기초한 계통분류학적 분석을 실시한 결과, 및 도 3의 b는 API 키트 분석을 실시한 결과이다.
도 4는, 발효 균주별 배양 기간에 따른 섬애쑥 발효물의 pH 변화를 측정한 결과이다.
도 5는, 발효 균주별 배양 기간에 따른 섬애쑥 발효물의 산도 변화를 측정한 결과이다.
도 6은, 발효 균주별 발효에 따른 α-glucosidase의 저해 활성을 비교한 결과이다. 1 is a comparison of the appearance characteristics of the common mugwort and island mugwort, a of Figure 1 is a result of visual observation of the common mugwort, and Figure 1 b is a result of visual observation of the island mugwort.
Figure 2 shows the results of analysis of the cell fatty acid composition of the strain isolated from Sanyacho fermentation broth by GLC.
FIG. 3 shows the strains isolated from the fermented broth of Sanyacho, a of FIG. 3 shows a phylogenetic analysis based on 16S rDNA sequencing, and b of FIG. 3 shows the results of API kit analysis.
Figure 4 is the result of measuring the pH change of the island mulberry fermentation according to the culture period for each fermentation strain.
Figure 5 is a result of measuring the acidity change of the island mulberry fermentation according to the culture period for each fermentation strain.
6 is a result of comparing the inhibitory activity of α-glucosidase according to fermentation strains.
이하, 본 발명을 상세히 설명하기로 한다. Hereinafter, the present invention will be described in detail.
본 발명은 섬애쑥 추출물을 유산균 또는 유산균의 배양물로 발효시킨, 알파-글루코시다아제 저해 활성이 증진된 섬애쑥 발효물을 제공한다. The present invention provides a wormwood fermented product having an enhanced alpha-glucosidase inhibitory activity, wherein the wormwood extract is fermented with a culture of lactic acid bacteria or lactic acid bacteria.
본 발명에서 사용되는 용어, "섬애쑥"은 황해쑥(Artemisia argyi)의 변이종으로서 남해 지역에서 자생하는 약쑥(남해 약쑥)으로 알려져 있고, 초년기에는 잎의 형태가 국화 잎처럼 끝이 둥글고 넓은 편이며, 줄기가 가늘고 흰 솜털이 많은 형태로 전체 길이가 50cm 내외로 자라는 특성이 있다. 도 1에 나타낸 바와 같이, 섬애쑥은 삼각상 난형으로 중부 잎의 접힘이 심한 일반 쑥과 달리, 마름모형으로 평평한 상태를 유지한다. 이 밖에도 섬애쑥과 일반 쑥간 일반적 특성의 차이는 하기 표 1과 같다.As used in the present invention, the term "Island Artemisia" is a mutant of Artemisia argyi and is known as a wormwood (Namhae wormwood) that grows in the South Sea region. In early years, the leaf form is round and wide like a chrysanthemum leaf. The stem is thin and has many white fluffy forms, and its overall length is about 50cm. As shown in Figure 1, the island wormwood is a triangular ovate, unlike the common wormwood with a severe fold of the central leaf, it maintains a flat state with a rhombus. In addition, the difference between the general characteristics between the island mugwort and common mugwort is shown in Table 1 below.
[표 1]TABLE 1
상기 표 1에 나타낸 바와 같이, 섬애쑥은 일반 쑥과 명백히 구별되는 특성을 지닌다. 구체적으로, 일반 쑥의 향보다 부드러운 박하향 비슷한 향이 나고, 섬유질이 풍부하여 뜸으로 제조시 연기가 적으며, 특히 향이 우수한 특징이 있다. 본 발명에서는, 섬애쑥의 기능성에 초점을 두어, 항산화 및 항당뇨 효과, 특히 당뇨 치료의 주요 기전으로 알려진 알파-글루코시다아제 저해 활성을 증진시킬 뿐만 아니라, 섬애쑥 고유의 쓴 맛을 해소하고 전체적인 기호도를 향상시키기 위하여, 섬애쑥 추출물을 특정 유산균 및 조건 하에서 발효시켰다는 점에 기술적 특징이 있다. As shown in Table 1, the island mugwort has a distinctive characteristic from the ordinary mugwort. Specifically, the smell of soft peppermint flavor than the scent of ordinary mugwort, the fiber is rich, there is less smoke during the production of moxibustion, and in particular, the flavor is excellent. In the present invention, focusing on the functionalities of the fungus, it not only enhances the antioxidant and anti-diabetic effect, especially the alpha-glucosidase inhibitory activity known as the main mechanism of diabetes treatment, but also eliminates the bitter taste inherent in the fungus In order to improve the palatability, there is a technical feature in that the extract from the wormwood was fermented under specific lactic acid bacteria and conditions.
본 발명에서, 섬애쑥 추출물은 천연물로부터 추출물을 추출하는 당업계에 공지된 통상적인 방법에 따라, 즉, 통상적인 온도, 압력의 조건 하에서 통상적인 용매를 사용하여 추출할 수 있다. 예컨대, 본 발명에서 섬애쑥 추출물은 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합 용매로 이루어진 군으로부터 선택된 1종 이상 용매를 사용하여 추출할 수 있으며, 바람직하게는 물을 사용할 수 있다. 또한, 섬애쑥으로부터 추출물을 추출하는 방법은 열수 추출, 냉침 추출, 환류 추출, 초음파 추출 등의 다양한 방법을 통하여 추출할 수 있지만, 이에 제한되는 것은 아니다. In the present invention, the wormwood extract can be extracted according to a conventional method known in the art for extracting the extract from natural products, that is, using a conventional solvent under the conditions of conventional temperature, pressure. For example, in the present invention, the mugwort extract may be extracted using one or more solvents selected from the group consisting of water, alcohols having 1 to 4 carbon atoms, and mixed solvents thereof, and preferably water may be used. In addition, the method of extracting the extract from the island mugwort can be extracted through various methods such as hot water extraction, cold needle extraction, reflux extraction, ultrasonic extraction, but is not limited thereto.
본 발명에서, 상기 발효를 위한 균주, 보다 구체적으로, 유산균은 바람직하게, 락토바실러스 브레비스, 류코노스톡 메센테로이데스, 또는 락토바실러스 플란타륨일 수 있으며, 보다 바람직하게, 락토바실러스 브레비스일 수 있고, 가장 바람직하게, 산야초 발효액으로부터 분리된 락토바실러스 브레비스, 즉, 락토바실러스 브레비스 osl 3 균주 (Lactobacillus brevis osl 3, KFCC 11715P)일 수 있으나, 이에 제한되는 것은 아니다. In the present invention, the strain for fermentation, more specifically, lactic acid bacteria may preferably be Lactobacillus brevis, Leukonostock mesenteroides, or Lactobacillus plantarium, more preferably, Lactobacillus brevis, Most preferably, Lactobacillus brevis, ie, Lactobacillus brevis 3 strain ( Lactobacillus brevis , isolated from wild vinegar fermentation broth)
본 발명에서 사용되는 용어, "발효"는 미생물이나 이들의 효소로 유기물을 분해하여 인간에게 유용한 물질을 얻어내는 과정을 일컬으며, 상기 발효 과정에 의해 생성된 물질을 발효물이라고 한다. 본 발명의 목적상 상기 유용한 물질은 기호도 및 기능성이 증진된, 구체적으로, 알파-글루코시다아제 저해 활성이 증진된 섬애쑥 발효물을 의미한다. The term "fermentation" used in the present invention refers to a process of obtaining a substance useful to humans by decomposing organic substances with microorganisms or enzymes thereof, and the substance produced by the fermentation process is called a fermentation product. The useful substance for the purpose of the present invention refers to a wormwood fermented product having enhanced palatability and functionality, specifically, enhanced alpha-glucosidase inhibitory activity.
본 발명의 다른 양태로서, 섬애쑥 추출물에 유산균 또는 유산균의 배양물을 첨가하여 발효시키는 단계를 포함하는, 알파-글루코시다아제 저해 활성이 증진된 섬애쑥 발효물의 제조방법을 제공한다. In another aspect of the present invention, there is provided a method for producing a wormwood fermented cabbage with enhanced alpha-glucosidase inhibitory activity, comprising the step of fermenting by adding a culture of lactic acid bacteria or lactic acid bacteria to the wormwood extract.
본 발명의 제조방법은 상술한 섬애쑥 발효물을 대상으로 하기 때문에, 이 둘 사이에 공통된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여, 그 기재를 생략한다.Since the production method of the present invention targets the above-mentioned wormwood fermented products, the contents common between the two are omitted in order to avoid excessive complexity of the present specification.
한 구체예로서, 섬애쑥 추출물에 정제수 및 영양성분을 첨가하여 발효 전 혼합물을 형성한 후 또는 이와 동시에, 전술한 유산균이 첨가될 수 있으며, 상기 영양성분은 바람직하게 맥아 추출물, 보다 바람직하게 맥아 수추출물일 수 있으나, 유산균에 영양분, 특히 당 성분을 제공할 수 있는 물질이라면 제한없이 포함할 수 있다. In one embodiment, after adding the purified water and the nutrient to the extract of the wormwood to form a mixture before fermentation or at the same time, the above-described lactic acid bacteria may be added, the nutrient is preferably malt extract, more preferably malt water It may be an extract, but may be included without limitation, so long as it is a substance that can provide nutrients, especially sugar components to lactic acid bacteria.
또한 섬애쑥 발효물의 알파-글루코시다아제 저해 활성을 보다 증진시키기 위하여, 전술한 유산균이 첨가된 섬애쑥 추출물을 26 내지 32℃에서 48시간 내지 96시간 동안 배양시킬 수 있으나, 이에 제한되는 것은 아니다. In addition, in order to further enhance the alpha-glucosidase inhibitory activity of the fungus, the above-mentioned lactic acid bacteria can be incubated for 48 hours to 96 hours at 26 to 32 ℃, but is not limited thereto.
한편, 본 발명의 일 실시예에서는, 섬애쑥 발효물 제조를 위한 최적의 발효 균주를 동정하였으며, 상기 균주를 포함하는 다양한 균주를 이용하여 섬애쑥 발효물을 제조하였다(제조예 1 및 2 참조). 상기 섬애쑥 발효물은 발효 균주와 함께 48시간 내지 72시간 동안 배양시킨 경우, 균주에 있어서는 락토바실러스 브레비스를 사용한 경우, 생육 활성 및 산도 등이 우수함을 확인하였다(실시예 1 참조). 또한 본 발명의 다른 실시예에서는, 상기 섬애쑥 발효물은 섬애쑥 추출물에 비해 향상된 항산화 (DPPH 라디컬 소거활성) 및 항당뇨 효과(α-glucosidase 저해)를 보였으며, 섬애쑥 발효물의 우수한 생체 내 안정성 및 기호도 향상을 확인할 수 있었는바 (실시예 2 내지 4 참조), 본 발명에 따른 발효물은 프로바이오틱스 등 건강 기능성 식품의 유효성분으로 활용될 수 있을 것이다. On the other hand, in one embodiment of the present invention, the optimum fermentation strains for the preparation of the island of Wormwood fermentation was identified, using a variety of strains including the strain was prepared by the island of Wormwood (see Preparation Examples 1 and 2) . When the fungus fermented with S. aureus was incubated for 48 hours to 72 hours with the fermentation strain, it was confirmed that the Lactobacillus brevis is excellent in growth activity and acidity, etc. in the strain (see Example 1). In addition, in another embodiment of the present invention, the wormwood fermentation showed an improved antioxidant (DPPH radical scavenging activity) and antidiabetic effect (α-glucosidase inhibition) compared to the wormwood extract, excellent in vivo It was confirmed that the improvement in stability and acceptability (see Examples 2 to 4), the fermented product according to the present invention will be used as an active ingredient of health functional foods such as probiotics.
따라서, 본 발명의 또 다른 양태로서, 상기 방법에 의해 제조된 섬애쑥 발효물을 유효성분으로 포함하는, 항산화 및/또는 항당뇨 프로바이오틱스 조성물을 제공한다. Accordingly, as another aspect of the present invention, there is provided an antioxidant and / or antidiabetic probiotics composition comprising the wormwood fermented product prepared by the above method as an active ingredient.
본 발명의 조성물은 상술한 섬애쑥 발효물을 유효성분으로 이용하기 때문에, 이 둘 사이에 공통된 내용은 본 명세서의 과도한 복잡성을 피하기 위하여, 그 기재를 생략한다.Since the composition of the present invention uses the above-mentioned wormwood fermented product as an active ingredient, the contents common between the two are omitted in order to avoid excessive complexity of the present specification.
본 발명의 프로바이오틱스 조성물은 생리학적으로 허용 가능한 담체를 추가로 포함할 수 있으며, 담체와 함께 제제화되어 식품 및 사료첨가제로 제공될 수 있다. The probiotic composition of the present invention may further comprise a physiologically acceptable carrier, and may be formulated with the carrier to provide food and feed additives.
본 발명에서 용어, "생리학적으로 허용가능한 담체"란 생물체를 자극하지 않고 투여 화합물의 생물학적 활성 및 특성을 저해하지 않는 담체 또는 희석제를 말한다. 액상 용액으로 제제화되는 프로바이오틱스에 있어서 허용되는 약제학적 담체로는, 멸균 및 생체에 적합한 것으로서, 식염수, 멸균수, 완충식염수, 알부민 주사용액, 덱스트로즈 용액, 말토 덱스트린 용액, 글리세롤 및 이들 성분 중 1 성분 이상을 혼합하여 사용할 수 있으며, 필요에 따라 항산화제, 완충액, 정균제 등 다른 통상의 첨가제를 첨가할 수 있다. 또한 희석제, 분산제, 계면활성제, 결합제 및 윤활제를 부가적으로 첨가하여 수용액, 현탁액, 유탁액 등과 같은 주사용 제형, 환약, 캡슐, 과립 또는 정제로 제제화할 수 있다. 본 발명에서의 프로바이오틱스 제제의 품질 저하를 방지하기 위하여 첨가하는 결착제, 유화제, 보존제 등이 있고, 효용 증대를 위하여 사료에 첨가하는 아미노산제, 비타민제, 효소제, 향미제, 비단백질태 질소화합물, 규산염제, 완충제, 추출제, 올리고당 등이 있다. 그 외에도 사료 혼합제 등을 추가로 포함할 수 있으며 이에 한정된 것은 아니다.As used herein, the term "physiologically acceptable carrier" refers to a carrier or diluent that does not irritate an organism and does not inhibit the biological activity and properties of the administered compound. Acceptable pharmaceutical carriers in probiotics formulated as liquid solutions are sterile and biocompatible, which include saline, sterile water, buffered saline, albumin injectable solutions, dextrose solution, maltodextrin solution, glycerol and one of these components. More than one component can be mixed and used, and other conventional additives, such as antioxidant, buffer, and bacteriostatic agent, can be added as needed. In addition, diluents, dispersants, surfactants, binders, and lubricants may be additionally added to formulate into injectable solutions, pills, capsules, granules or tablets such as aqueous solutions, suspensions, emulsions and the like. There are binders, emulsifiers, preservatives, and the like added to prevent deterioration of the quality of the probiotic formulations in the present invention, and amino acids, vitamins, enzymes, flavors, nonprotein nitrogen compounds, and silicates added to the feed to increase the efficacy. Agents, buffers, extractants, oligosaccharides and the like. In addition, the feed mixture may further include, but is not limited thereto.
본 발명의 프로바이오틱스를 유효성분으로 포함하는 경구 투여용 제형으로는, 예를 들어 정제, 트로키제, 로렌지, 수용성 또는 유성현탁액, 조제분말 또는 과립, 에멀젼, 소프트 캡슐로 제제화할 수 있다. 정제 및 캡슐 등의 제형으로 제제화 하기 위해, 락토오스, 사카로오스, 솔비톨, 만니톨, 전분, 아밀로펙틴, 셀룰로오스 또는 젤라틴과 같은 결합제, 디칼슘 포스페이트와 같은 부형제, 옥수수 전분 또는 고구마 전분과 같은 붕괴제, 스테아르산 마그네슘, 스테아르산 칼슘, 스테아릴푸마르산 나트륨 또는 폴리에틸렌글리콜 왁스와 같은 윤활류를 포함할 수 있으며, 캡슐 제형의 경우 상기 언급한 물질 외에도 지방유와 같은 액체 담체를 더 함유할 수 있다.Formulations for oral administration containing the probiotics of the present invention as an active ingredient, for example, can be formulated into tablets, troches, lozenges, water-soluble or oily suspensions, prepared powders or granules, emulsions, soft capsules. For formulation into tablets and capsules, lactose, saccharose, sorbitol, mannitol, starch, amylopectin, binders such as cellulose or gelatin, excipients such as dicalcium phosphate, disintegrants such as corn starch or sweet potato starch, magnesium stearate And lubricating agents such as calcium stearate, sodium stearyl fumarate or polyethylene glycol wax, and the capsule formulation may further contain a liquid carrier such as fatty oil in addition to the aforementioned substances.
또한, 본 발명의 또 다른 양태로서, 상기 방법에 의해 제조된 섬애쑥 발효물을 유효성분으로 포함하는, 항산화용 화장료 조성물, 또는 항산화 및/또는 항당뇨용 약학적 조성물 제공한다. In still another aspect of the present invention, there is provided a cosmetic composition for antioxidant, or an antioxidant and / or antidiabetic pharmaceutical composition, which comprises the wormwood fermented product prepared by the method as an active ingredient.
또한, 본 발명의 또 다른 양태로서, 본 발명은 우수한 섬애쑥 발효 효능을 지닌 균주를 제공한다. In addition, as another aspect of the present invention, the present invention provides a strain having excellent fungus fermentation efficacy.
본 발명의 균주는 쑥, 머위 등 산야초 발효액으로부터 분리되었으며, 상기 분리된 균주의 분자생물학적 특성을 16S rDNA 유전자 염기서열로 분석하여, 락토바실러스 브레비스(Lactobacillus brevis)와 높은 상동성을 보이는 신규한 균주를 동정하였다. 상기 균주를 락토바실러스 브레비스 osl 3 (Lactobacillus brevis osl 3)로 명명하였고, 한국미생물보존센터에 2016월 12월 13일자로 기탁하여 기탁번호 KFCC 11715P를 부여받았다. The strain of the present invention was isolated from wild vinegar fermentation broth such as mugwort, butterbur, and analyzed the molecular biological characteristics of the isolated strain by 16S rDNA gene sequence, a novel strain showing high homology with Lactobacillus brevis ( Lactobacillus brevis ) I identified it. Lactobacillus brevis (Sactobacillus brevis) osl 3) and was deposited with the Korea Microorganism Conservation Center on December 13, 2016 and was given accession number KFCC 11715P.
본 발명의 균주를 프로바이오틱스로 사용하는 경우, 발효물, 특히 섬애쑥 발효물에서, 섬애쑥 고유의 쓴 맛을 약화시키고, 높은 항산화 또는 항당뇨 효과가 나타내는바, 상기 균주 또는 이의 배양물은 프로바이오틱스 조성물의 제조에 유용하게 사용할 수 있다. When the strain of the present invention is used as a probiotics, in fermented products, especially wormwood fermented products, the bitterness inherent in the wormwood is weakened, and high antioxidant or antidiabetic effects are indicated, and the strain or its culture is a probiotic composition. It can be usefully used for the preparation of.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are merely provided to more easily understand the present invention, and the contents of the present invention are not limited by the following examples.
[[ 제조예Production Example ]]
제조예Production Example 1. One. 락토바실러스Lactobacillus 브레비스Brevis oslosl 3 균주의 분리 및 동정 Isolation and Identification of Three Strains
본 발명자들은 섬애쑥 발효물의 제조를 위한 발효 균주를 수득하고자, 쑥, 머위 등 산야초 발효액으로부터 균주를 분리하였다. 적당히 희석한 산야초 발효액을 유산균 분리용 배지인 MRS 한천배지 (DifcoTM Becton, Dickinson & Co., USA)에 도말하고 30℃에서 3-5일간 배양하여 단일 집락을 형성시킨 후, 유산균 특유의 집락을 새로 만든 MRS 한천배지에서 순수분리하였다. 순수하게 분리된 집락은 121℃에서 15분 멸균한 맥아 추출액에 접종하고 30℃에서 150rpm으로 2일간 진탕배양 한 후, 섬애쑥 추출물 기질 (섬애쑥 추출물과 맥아 추출물을 1:1의 비율로 혼합한 기질)에 1% (v/v) 농도로 접종하고 30℃에서 4일간 정치 발효시킨 뒤, 향과 맛을 포함하는 전반적인 풍미를 검토하여, 발효적성이 우수하다고 판단되는 균주를 선별하였다. 이후, 상기 균주를 대상으로 탄소원 이용성, 세포 지방산 분석, 및 16S rDNA 염기서열 분석에 의한 계통발생학적 연구를 실시하였다. In order to obtain a fermentation strain for the preparation of the island mulberry fermentation, the present inventors isolated the strain from wild vinegar fermentation broth such as mugwort, butterbur. Appropriate dilution of fermented broth in MRS agar medium (Difco TM Becton, Dickinson & Co., USA), a medium for lactic acid bacteria separation, and incubated at 30 ° C for 3-5 days to form a single colony. Pure water was separated from freshly prepared MRS agar medium. The purely isolated colonies were inoculated in a sterilized malt extract at 121 ° C. for 15 minutes and shaken at 30 ° C. for 150 days at 150 rpm. The substrate was inoculated at a concentration of 1% (v / v) and allowed to ferment for 4 days at 30 ° C., and then, the overall flavors including flavor and taste were examined, and strains judged to have excellent fermentation aptitude were selected. Thereafter, the strains were subjected to phylogenetic studies by carbon source availability, cellular fatty acid analysis, and 16S rDNA sequencing.
우선, 상기 균주의 탄소원 이용성을 APL 50 CHL 키트를 이용하여 검사한 결과, 하기 표 2에 나타낸 바와 같이, L-Arabinose, Ribose, D-Xylose, β-Methyl-xyloside, Galactose, D-Glucose, D-Fructose, N-Acethyl-glucosamine, Esculine,Maltose, Melibiose 등의 탄소원을 이용할 수 있으며, 이러한 결과로부터 Lactobacillus brevis 또는 Lactobacillus buchneri 근연종으로 판단할 수 있었다. First, the carbon source availability of the strain was examined using an
[표 2]TABLE 2
또한, 상기 균주의 세포 지방산 조성을 GLC로 분석한 결과, 하기 표 3 및 도 2에 나타낸 바와 같이, C16 ~ C20의 다양한 포화, 불포화, 분지, 환상, 알코올 지방산을 함유하고 있었으며, 기존의 data base와 비교할 때, Leuconostoc mesenteroides 근연종으로 추론해볼 수 있었다. In addition, as a result of analyzing the cell fatty acid composition of the strain by GLC, as shown in Table 3 and Figure 2, it contained a variety of C 16 ~ C 20 saturated, unsaturated, branched, cyclic, alcohol fatty acid, the existing data In comparison with the base, Leuconostoc mesenteroides can be inferred.
[표 3][Table 3]
아울러, 16S rDNA 염기서열에 기초한 계통분류학적 분석 및 API 키트 분석을 실시한 결과, 도 3에 나타낸 바와 같이, 최종적으로, 상기 균주는 락토바실러스(Lactobacillus) 속에 속하는 균주로서, 약 99%의 16S rDNA 상동성으로 락토바실러스 브레비스(Lactobacillus. brevis) 균주와 가장 높은 분자계통학적 유연관계를 나타내는 균주로 동정되었으며, 이하, 이를 L. brevis . osl 3 또는 osl 3으로 명명하였다.In addition, as a result of phylogenetic analysis and API kit analysis based on the 16S rDNA sequence, as shown in Figure 3, finally, the strain belongs to the genus Lactobacillus ( Lactobacillus ), about 99% of the 16S rDNA phase Same as Lactobacillus brevis (Lactobacillus. brevis) strain and the strain was identified as exhibiting a high molecular phylogenetic relationship flexible, hereinafter it L. brevis. We named it osl 3 or
제조예Production Example 2. 2. 섬애쑥Island 발효물의Fermented 제조 Produce
경상남도 남해군 아산리에서 육성한 섬애쑥을 채취하여 이를 세척 및 건조시키고, 상기 건조된 섬애쑥 10g에 증류수 90g을 첨가하여 섬애쑥 수추출물을 제조하였다. 상기 섬애쑥 수추출물은 121℃에서 30분 동안 고압증기멸균(Autoclave) 처리되었으며, 여기에 다시 증류수를 첨가하여 전체 용액의 부피가 100mL에 이르도록 하였다. 이후, 상기 100mL의 용액에 다양한 종류의 발효 균주를 2% (v/v) 농도로 첨가한 후, 약 30℃에서, 맥아 추출물 (100mL)과 함께 4일 동안 배양하여 섬애쑥 발효물을 제조하였다. 상기 맥아 추출물은 맥아 100g에 1L의 증류수를 첨가하고, 60℃에서 2시간 동안 항온시킨 뒤, 121℃에서 15분간 가열 추출하여 수득한 여액을 10L로 조정하여 제조하였다. The islands mugwort grown in Asan-ri, Namhae-gun, Gyeongsangnam-do was collected, washed and dried, and 90 g of distilled water was added to 10 g of the dried islands mugwort to prepare an extract. The mugwort water extract was subjected to autoclave treatment at 121 ° C. for 30 minutes, and distilled water was added thereto so that the total solution volume reached 100 mL. Thereafter, various kinds of fermentation strains were added to the 100 mL solution at a concentration of 2% (v / v), and then cultured at about 30 ° C. with malt extract (100 mL) for 4 days to prepare fermented cabbage. . The malt extract was prepared by adding 1 L of distilled water to 100 g of malt, incubating at 60 ° C. for 2 hours, and adjusting the filtrate obtained by heating and extracting at 121 ° C. for 15 minutes to 10 L.
한편, 섬애쑥 발효물의 제조를 위한 발효 균주로, 락토바실러스 브레비스, 락토바실러스 브레비스 osl 3, 류코노스톡 메센테로이데스, 또는 락토바실러스 플란타륨(이하, 각각을 L. brevis(Lb), L. brevis . osl 3, L. mesentorides(Lm), L.plantarium(Lp)으로 명명함.)을 사용하였다. On the other hand, the island aessuk the fermentation strain for the preparation of fermentation, Lactobacillus brevis,
[[ 실시예Example ]]
실시예Example 1. 배양 기간에 따른 균 수 등의 변화 1. Changes in the number of bacteria, etc. according to the culture period
본 실시예에서는, 다양한 종류의 발효 균주를 접종하여 제조된 상기 제조예 1의 섬애쑥 발효물에 대하여, 배양 기간에 따른 섬애쑥 발효물의 pH 및 산도 변화와 균주의 생육 상태를 평가하였다. 구체적으로, 각각의 섬애쑥 발효물을 총 96시간 동안 배양하면서, 12시간 간격으로 상기 발효물 내 pH, 산도, 및 생육 중인 균 수를 산출하였고, 대조군으로는 발효 균주를 접종하지 않은 섬애쑥 수추출물 및/또는 L.brevis. osl 3을 이용하여 맥아 추출물만 발효시킨 군을 이용하였다. In this example, the pH and acidity changes of the fungus fermentation product according to the culture period and the growth state of the strains were evaluated for the fungus fermentation of Preparation Example 1 prepared by inoculating various types of fermentation strains. Specifically, while cultivating each of the fungus fermented for 96 hours, the pH, acidity, and number of bacteria in the fermentation were calculated at 12 hour intervals, and the control was not inoculated with the fermentation strains Extracts and / or L.brevis.
그 결과, 도 4 및 도 5에 나타낸 바와 같이, 발효 균주를 접종하지 않은 섬애쑥 수추출물은 pH 및 산도의 변화가 거의 없었던 반면, 발효 균주를 처리한 나머지 군 (맥아+osl 3, osl 3, Lb, Lm, 및 Lp)에서는, pH 저하와 산도 증가가 관찰되었는바, 발효가 진행됨을 알 수 있었고, 특히, L. brevis . osl 3, L. brevis , 또는 L.plantarium을 사용한 경우, 이러한 변화는 보다 현저하였다. As a result, as shown in Figs. 4 and 5, while the extracts of the wormwood without inoculation fermentation strain had little change in pH and acidity, the remaining groups treated with fermentation strains (malt +
또한, 하기 표 4에 나타낸 바와 같이, 맥아 추출물에 의한 우수한 증식 효과는, 다양한 균주를 접종하여 발효시킨 본 발명의 섬애쑥 발효물 내에서도 유효하게 유지됨을 확인할 수 있었다. 대부분의 섬애쑥 발효물은, 배양시간이 48시간 또는 72시간인 경우, 증식된 균의 수가 최대치에 이르게 됨을 알 수 있었으며, 특히, 이 중에서도 L. brevis . osl 3 또는 L. brevis를 발효 균주로 사용한 경우, 섬애쑥 발효물 내 균의 생육이 가장 양호하였다. In addition, as shown in Table 4, it was confirmed that the excellent proliferative effect by the malt extract is effectively maintained even in the fermented barley of the present invention inoculated with various strains. Most of the fungus fermented with S. aureus, it was found that when the incubation time is 48 hours or 72 hours, the number of grown bacteria reaches the maximum value, among which L. brevis . When osl 3 or L. brevis was used as the fermentation strain, the growth of the fungus in the fungus fermentation was the best.
[표 4][Table 4]
실시예Example 2. 2. 섬애쑥Island 발효물의Fermented 기능성 증진 효과 확인 Confirmation of functional enhancement effect
본 실시예에서는, 섬애쑥 발효물의 항산화 효능의 평가하고자, 발효 전 후의 총 페놀 함량을 Folin-Ciacalteu's 방법으로 측정하였으며, DPPH(1,1-diphenyl-2-picryl-hydrazyl) 라디컬 소거활성 실험을 실시하였다. 이와 함께, 섬애쑥 발효물의 항당뇨 효과를 평가하고자, 발효 균주 및 발효 유무에 따른, 당뇨병 치료와 밀접한 관계가 있는 것으로 알려진 α-glucosidase의 활성 변화를 측정하였다. 한편, 대조군으로는 발효 균주를 접종하지 않은 섬애쑥 수추출물을 이용하였다. In the present Example, to evaluate the antioxidant efficacy of the Pleurotus eryngii fermentation, the total phenol content before and after fermentation was measured by Folin-Ciacalteu's method, and DPPH (1,1-diphenyl-2-picryl-hydrazyl) radical scavenging activity test was performed. Was carried out. In addition, in order to evaluate the anti-diabetic effect of S. aureus fermentation, the activity change of α-glucosidase, which is known to be closely related to the treatment of diabetes mellitus according to the fermentation strain and the presence or absence of fermentation, was measured. On the other hand, as a control was used as the extract of the island wormwood not inoculated with the fermentation strain.
그 결과, 하기 표 5에 나타낸 바와 같이, 발효 균주를 이용하여 섬애쑥 추출물을 발효시킨 경우, 총 페놀의 함량은 비록 대조군에 비해 다소 낮게 관찰되었으나, 직접적인 항산화 효과의 지표로 이용되고 있는 DPPH 라디컬 소거활성은 대조군에 비해 다소 높아짐을 확인할 수 있었다. 구체적으로, 발효 균주를 이용하여 맥아 추출물만을 발효시킨 경우, DPPH 라디컬 소거 활성은 매우 낮게 관찰된 반면, 섬애쑥 발효물은 그 효과가 현저하게 증진되었으며, 상기와 마찬가지로, L. brevis . osl 3 또는 L. brevis를 발효 균주로 사용한 경우, 이러한 효과는 보다 우수하였다(84.76%, 84,41%). 특히, 일반 쑥과 솔잎의 항산화 작용 및 아질산염 소거작용 관련 문헌(2002, 박찬성외, 한국식품저장유통학회)에 의하면, 쑥의 물 추출물과 에탄올 추출물의 전자 공여능을 조사한 결과, 물 추출물은 100, 300, 500, 1000ppm의 농도에서 전자 공여능이 각각 41, 50, 53, 57%이고, 에탄올 추출물은 39, 51, 58, 64%를 나타내었다는 점을 고려해 볼 때, 섬애쑥 발효물의 이러한 결과는 일반 쑥에 비해 현저하게 우수한 효과임을 알 수 있다. As a result, as shown in Table 5 below, when fermentation of S. aureus extract using a fermentation strain, although the total phenolic content was observed slightly lower than that of the control group, DPPH radicals used as an indicator of direct antioxidant effect Scavenging activity was found to be somewhat higher than the control. Specifically, when only malt extract was fermented using a fermentation strain, DPPH radical scavenging activity was observed to be very low, whereas the wormwood fermented product significantly enhanced its effect, and as described above, L. brevis . When osl 3 or L. brevis was used as the fermentation strain, this effect was better (84.76%, 84,41%). In particular, according to the literature on the antioxidant and nitrite scavenging activity of mugwort and pine needles (2002, Chan-Sung Park et al., Korean Society of Food Preservation and Distribution), the water extract was 100, 300 Considering that the electron donating abilities were 41, 50, 53, 57%, and
[표 5]TABLE 5
또한, 섬애쑥 발효물의 항당뇨 효과를 평가한 결과, 발효 균주를 이용하여 섬애쑥 추출물을 발효시킨 경우, 발효 전에 비해 α-glucosidase 저해 활성이 유의적으로 증가됨을 알 수 있었다(도 6 참조). 이러한 효과는 섬애쑥을 함유하는 대조군 및 L. brevis . osl 3을 이용하여 맥아 추출물만을 발효시킨 군에 비해서도 현저하였으며, 특히, 이 중에서도 L. brevis . osl 3을 발효 균주로 사용한 경우, α-glucosidase 저해 활성이 가장 우수하였다. In addition, as a result of evaluating the anti-diabetic effect of the mugwort fermentation, it was found that when the mugwort extract was fermented using the fermentation strain, α-glucosidase inhibitory activity was significantly increased compared to before fermentation (see FIG. 6). These effects are found in control and contain L. brevis . It was also remarkable compared to the group in which only malt extract was fermented using
실시예Example 3. 3. 섬애쑥Island 발효물의Fermented 안정성 분석 Stability analysis
본 실시예에서는, 상기 실시예 1 및 2에서 우수한 효과를 보였던 발효 균주인 L. brevis . osl 3 또는 L. brevis를 대상으로 이들의 내담즙산성 및 pH 안정성을 평가함으로써, 본 발명의 섬애쑥 발효물이 프로바이오틱스 등 건강 기능성 식품으로 활용될 수 있는지 확인하고자 하였다. In this example, L. brevis . Fermentation strains showed excellent effects in Examples 1 and 2 .
3-1. 발효 균주의 3-1. Fermentation strains 내담즙산성Bile Acid Resistance 분석 analysis
배지에 0.5 또는 1.0%의 담즙산을 첨가한 뒤, L. brevis . osl 3 또는 L.brevis를 배양하면서, 이에 따른 생육 변화를 OD 값을 측정하여 분석한 결과, 하기 표 6에 나타낸 바와 같이, 두 균주 모두, 첨가되는 담즙산의 함량이 증가할수록 생육이 저해되는 경향을 보였으나, 배양 기간이 경과함에 따라 균의 생육이 적정 수준 이상으로 이루어짐을 확인할 수 있었으며, L. brevis에 비해 L. brevis . osl 3 균주의 생육 활성이 보다 양호함을 알 수 있었다. After addition of 0.5 or 1.0% bile acid to the medium, L. brevis .
[표 6]TABLE 6
3-2. 발효 균주의 pH 안정성 분석3-2. PH Stability Analysis of Fermented Strains
2N-HCl을 첨가하여 배지의 pH를 각각 pH 6.7, pH 3.0, pH 2.0으로 조정한 뒤, L. brevis . osl 3 또는 L. brevis를 배양하면서 이에 따른 균 수의 변화를 분석한 결과, 하기 표 7에 나타낸 바와 같이, 두 균주 모두, 배지의 pH가 낮아질수록 생육이 저해되는 경향을 보였으나, 배양 기간이 경과함에 따라 균의 생육이 어느 정도 회복되거나 증가됨을 확인할 수 있었으며, 상기와 마찬가지로, L. brevis에 비해 L.brevis. osl 3 균주의 pH 안정성이 보다 우수함을 알 수 있었다. 2N-HCl was added to adjust the pH of the medium to pH 6.7, pH 3.0 and pH 2.0, respectively, followed by L. brevis . As a result of analyzing the change in the number of bacteria according to the culture of
[표 7]TABLE 7
실시예Example 4. 4. 섬애쑥Island 발효물의Fermented 관능 평가 Sensory evaluation
약쑥은 고유의 쓴 맛으로 인해 가공 식품으로 활용함에 어려움을 겪고 있는바, 이를 개선할 수 있는 기술이 필요한 실정이다. 본 실시예에서는, 다양한 종류의 발효 균주를 접종하여 제조된 상기 제조예 1의 섬애쑥 발효물에 대한 관능 검사를 색, 맛, 향으로 구분하여 검사하여 기호성의 증진 여부를 평가하였다. 본 관능 검사는 20명을 대상으로 9점 채점법으로 시행하였으며, 대조군으로는 발효 균주를 접종하지 않은 섬애쑥 수추출물을 이용하였다.The wormwood is difficult to use as a processed food due to the inherent bitter taste, the situation is required to improve the technology. In the present embodiment, the sensory test of the wormwood fermented product of Preparation Example 1 prepared by inoculating various types of fermentation strains was tested by color, taste, and aroma to evaluate the improvement of palatability. The sensory test was carried out by nine-point scoring method for 20 patients.
그 결과, 표 8에 나타낸 바와 같이, 발효되지 않은 대조군에 비해, 섬애쑥 발효물은 색이 개선되고, 쓴 맛이 감소되는 등 전체적인 기호도가 향상되었으며, 이 중에서도 L. brevis . osl 3 또는 L. brevis를 발효 균주로 사용한 경우, 각각 6.5 및 6.4로 기호도 향상 효과가 매우 우수한 것으로 나타났다. As a result, as shown in Table 8, compared with the non-fermented control, the ginseng fermented product improved the overall acceptability such as improved color and reduced bitter taste, among which L. brevis . When osl 3 or L. brevis was used as the fermentation strain, 6.5 and 6.4, respectively, were found to have excellent palatability improvement effects.
[표 8][Table 8]
이상 설명한 것과 같이, 본 발명에 따른 섬애쑥 발효물은 섬애쑥 추출물에 비해 항산화 또는 항당뇨 효과가 증진되었을 뿐만 아니라, 다양한 계층에서도 쉽게 음용할 수 있도록 기호성이 유의적으로 향상되었는바, 프로바이오틱스 등 건강 기능성 식품의 유효성분으로 활용될 수 있을 것이다. As described above, the barley mugwort fermented product according to the present invention has not only enhanced antioxidant or antidiabetic effects compared to barley mugwort extract, but also significantly improved palatability so that it can be easily consumed in various layers, such as probiotics. It can be used as an active ingredient of functional foods.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.The foregoing description of the present invention is intended for illustration, and it will be understood by those skilled in the art that the present invention may be easily modified in other specific forms without changing the technical spirit or essential features of the present invention. will be. It is therefore to be understood that the above-described embodiments are illustrative in all aspects and not restrictive.
Claims (8)
Alpha-Fructus extract was fermented with lactic acid bacteria or cultures thereof selected from the group consisting of Lactobacillus brevis , Leuconostoc mesenteroides , and Lactobacillus plantarum . A wormwood fermented product with enhanced glucosidase (α-glucosidase) inhibitory activity.
According to claim 1, The extract of the island of Artemisia is an extract of the island of mugwort, island mugwort fermentation.
According to claim 1, The lactic acid bacteria Lactobacillus brevis osl 3 strains ( Lactobacillus brevis osl 3, KFCC 11715P), characterized in that the island mulberry fermentation.
상기 유산균은 락토바실러스 브레비스, 류코노스톡 메센테로이데스, 및 락토바실러스 플란타륨으로 이루어진 군으로부터 선택되는, 섬애쑥 발효물의 제조방법.
As a method for producing an α-glucosidase inhibitory activity, comprising a step of fermenting by adding a culture of lactic acid bacteria or lactic acid bacteria to an extract of the fungus,
The lactic acid bacterium is selected from the group consisting of Lactobacillus brevis, Leukonostock mesenteroides, and Lactobacillus plantarium, a method for producing a fungus fermented.
According to claim 4, Prior to the step of fermentation, further comprising the step of forming a mixture before fermentation by adding purified water and malt extract to the mulberry extract, fermented mulberry fermentation.
The method of claim 4, wherein the lactic acid bacteria is Lactobacillus brevis osl 3 strain ( Lactobacillus brevis osl 3, KFCC 11715P), characterized in that the preparation method of the island mulberry fermentation.
The method of claim 4, wherein the step of fermentation, characterized in that carried out for 48 to 96 hours at 26 to 32 ℃, wormwood fermented product.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160152318 | 2016-11-16 | ||
KR20160152318 | 2016-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180055710A KR20180055710A (en) | 2018-05-25 |
KR102007569B1 true KR102007569B1 (en) | 2019-08-05 |
Family
ID=62299893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170149248A KR102007569B1 (en) | 2016-11-16 | 2017-11-10 | Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102007569B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102558938B1 (en) * | 2022-11-30 | 2023-07-25 | 주식회사 동성푸드 | Method of processing livestock and livestock processed thereby |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002330725A (en) * | 2001-03-07 | 2002-11-19 | Ryukyu Bio Resource Kaihatsu:Kk | Fermented food material, method for producing the same, drink or food, and extract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101246143B1 (en) * | 2011-06-28 | 2013-03-21 | 주영철 | Composition prepared by fermenting extract from Artemisia showing osteoblast proliferation activity |
-
2017
- 2017-11-10 KR KR1020170149248A patent/KR102007569B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002330725A (en) * | 2001-03-07 | 2002-11-19 | Ryukyu Bio Resource Kaihatsu:Kk | Fermented food material, method for producing the same, drink or food, and extract |
Also Published As
Publication number | Publication date |
---|---|
KR20180055710A (en) | 2018-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108936164B (en) | Lactobacillus rose enzyme beverage and preparation method thereof | |
CN113604395B (en) | Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof | |
CN104489092A (en) | Health drink containing grosvener siraitia extract and active bifidobacterium longum and preparation method for health drink containing grosvener siraitia extract and active bifidobacterium longum | |
CN107242555A (en) | A kind of hypoglycemic fruit zymotic fluid and preparation method thereof | |
KR20140051543A (en) | Method for producing fermented herb extract with high gaba content using lactobacillus plantarum k154 | |
CN104164459A (en) | Method utilizing fermentation to improve gamma-aminobutyric acid content of brown rice | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
JP6955808B1 (en) | How to make fermented honey | |
US20230364166A1 (en) | Application of postbiotics of inactivated lactobacillus casei iob-p9 in blood glucose reducing | |
KR102007569B1 (en) | Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same | |
KR20200084829A (en) | Composition for anti-virus Comprising Nano-Sized Lactic Acid Bacteria from Kimchi | |
CN109247474B (en) | Application of lactobacillus plantarum in preparation of lactobacillus rose fermented beverage | |
CN116948884A (en) | Lactobacillus delbrueckii subspecies with high biofilm formation and strong stress resistance and application thereof | |
KR101814941B1 (en) | Food composition for anti-oxidation comprising cockscomb flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof | |
KR100630337B1 (en) | Process for preparing Opuntia ficus-indica fruit powder and milk product by fermentation | |
KR101407231B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 | |
KR100642798B1 (en) | Fermentation liquor using microorganisms from bamboo, and the use thereof | |
KR20160030754A (en) | Fermented coffee using effective microorganisms and manufacturing method thereof | |
CN103966139A (en) | Lactobacillus brevis capable of producing gamma-aminobutyric acid at high yield in Sichuan pickle vegetables | |
KR20200012236A (en) | Novel lactic acid bacteria and method of preparing fermented product having effect of anti-obesity and anti-diabets using the same | |
KR101685768B1 (en) | Processes for preparing fermented Lentil bean | |
KR101381950B1 (en) | Fermented tea of persimmon leaf and manufacturing method of the same | |
KR101286603B1 (en) | Jang food such as Doenjang containing Spirulina and the method of preparing same | |
KR101871904B1 (en) | Leuconostoc mesenteroides YSM1219 and its use | |
JP2019071879A (en) | Production method of lactic acid fermented carrot |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |